AstraZeneca and the UK

Angie Szumlinski Health, Studies

A MedPage Today article reports that as Great Britain continues to stretch out the interval between the first and second doses of the COVID-19 vaccine to 12 weeks, data out this week seems to support doing so, but concerns remain. A study published in The Lancet showed that the AstraZeneca/Oxford vaccine provides sustained protection of 76% during the 12-week interval …

AHRQ Resources

Angie Szumlinski Featured

The Agency for Healthcare Research and Quality (AHRQ) has posted a list of resources for providers to use as we look forward or take steps back during the pandemic. Times are uncertain, change is a “norm” and your resilience has been amazing. That said, it might be time to look at the systems you have in place to be sure …

Is Single BNT162b2 Vaccine Effective

Angie Szumlinski Health, Studies

Recent studies have suggested that to reach immunity, immunocompetent SARS-CoV-2 seropositive adults may only require 1 dose rather than 2 doses of an mRNA vaccine, however, these studies did not include older adults. Older adults living in nursing homes are at higher risk for severe COVID-19, and the immune response to the vaccine may differ from that of younger, healthier …

Wuhan – More Research Needed

Angie Szumlinski News

The World Health Organization (WHO) report on the joint WHO-China study of COVID-19 origins was a “consensus” effort of a “sheer size” but it was too soon to provide definitive conclusions in a work that is still in progress, a member of the WHO research team said. Peter K. Ben Embarek, leader of the international team of experts to Wuhan, …

Loss of Smell and Taste

Angie Szumlinski Health, Studies

A study of about 200 COVID-19 patients last year found that nearly half reported a loss of taste or smell. While most of them regained their senses within four weeks, roughly 10% reported their condition had been unchanged or worse. Doctors are still learning about this COVID-19 related symptom and what possible treatments could be helpful. Some physicians have begun …

Vaccines Work

Angie Szumlinski Health, Studies

Clinical trials suggest high efficacy for COVID-19 vaccines, but evaluation of vaccine effectiveness against severe outcomes in real-world settings and in populations at high risk, including older adults, is needed. In a multistate network of U.S. hospitals during January-March 2021, receipt of Pfizer BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% …

Spreading Infection – Be Aware!

Angie Szumlinski Health, News

A New York Department of Health surveyor auditing a Bronx nursing home exposed residents and staff to COVID-19 per a source at Fox News. According to an employee at Pelham Parkway Nursing Home, a team of health department surveyors began auditing the facility on April 5. While department guidance “strongly encourages” all visitors to be tested before entering a nursing …

Dementia Increased Risk of COVID-19

Angie Szumlinski News

An estimated 5.8 million Americans age 65 and older and 50 million people worldwide are living with Alzheimer’s Disease and other dementias. Strong risk factors for cognitive decline and dementia include cardiovascular diseases, diabetes, obesity, and hypertension. Many of these common comorbidities in patients with dementia are also demonstrated risk factors for COVID-19 and are associated with worse clinical outcomes. …

Death Certificates – ICD-10 Diagnosis Code for COVID-19

Angie Szumlinski News

Among death certificates from calendar year 2020 listing COVID-19 and at least one other co-occurring diagnosis, the documentation is consistent with these deaths being attributable to COVID-19. Specifically, in 97% of 357,133 death certificates with COVID-19 and at least on other diagnosis, the documented chain-of-event and significant contributing conditions were consistent with those reported in clinical and epidemiologic studies to …

Inhaled COVID-19 Vaccine?

Angie Szumlinski Announcements, News

China is starting clinical trials for a COVID-19 vaccine that can be inhaled! Yes, China’s CanSino Biologics started clinical trials for a COVID-19 vaccine administered through inhalation at the end of April 2021. Per the company’s Chief Executive Xuefeng Yu, such a vaccine would be more effective than those injected given that the coronavirus enters the human body through the …